Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Bayley

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|July 25, 2009
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paragangliomaHuai-Xiang Hao, Oleh Khalimonchuk, Margit Schraders, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Mathematical Models for Tumor Growth and the Reduction of OvertreatmentBerdine L Heesterman, John-Melle Bokhorst, Lisa M H de Pont, et al.
BMC Medical Genetics|January 13, 2006
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytomaJean-Pierre Bayley, Ivonne van Minderhout, Marjan M Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
Mutation of SDHB is a cause of hypoxia-related high-altitude paragangliomaNidia Y Cerecer-Gil, Luis E Figuera, Francisco J Llamas, et al.
BMC Medical Genetics|April 17, 2009
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patientsJean-Pierre Bayley, Anneliese E M Grimbergen, Patrick A van Bunderen, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Research Square|February 6, 2026
Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistryCynthia Estrada-Zuniga, Rui Liang, Bethany Landry, et al.
Human Molecular Genetics|July 13, 2016
Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiersAttje S Hoekstra, Ruben D Addie, Cor Ras, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Nature Reviews. Endocrinology|November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas, Rodrigo A Toledo, Nelly Burnichon, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|July 25, 2009
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paragangliomaHuai-Xiang Hao, Oleh Khalimonchuk, Margit Schraders, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Mathematical Models for Tumor Growth and the Reduction of OvertreatmentBerdine L Heesterman, John-Melle Bokhorst, Lisa M H de Pont, et al.
BMC Medical Genetics|January 13, 2006
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytomaJean-Pierre Bayley, Ivonne van Minderhout, Marjan M Weiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2010
Mutation of SDHB is a cause of hypoxia-related high-altitude paragangliomaNidia Y Cerecer-Gil, Luis E Figuera, Francisco J Llamas, et al.
BMC Medical Genetics|April 17, 2009
The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patientsJean-Pierre Bayley, Anneliese E M Grimbergen, Patrick A van Bunderen, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Research Square|February 6, 2026
Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistryCynthia Estrada-Zuniga, Rui Liang, Bethany Landry, et al.
Human Molecular Genetics|July 13, 2016
Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiersAttje S Hoekstra, Ruben D Addie, Cor Ras, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Nature Reviews. Endocrinology|November 19, 2016
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas, Rodrigo A Toledo, Nelly Burnichon, et al.
Pageof 5